The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Direct-to-Patient
Clinical trials are essential for advancing medical science and developing new treatments. However, patient recruitment and retention have long been significant challenges in the clinical research process. Direct-to-patient (DtP) approaches seek to address these issues by engaging patients directly in clinical trials, outside the traditional healthcare system. In Israel, a country known for its thriving healthcare and life sciences sector, the adoption of DtP strategies in clinical trials is of particular interest.
Related Education Resources.
All ResourcesForecasting
Topics: EAP, Forecasting / Planning
Video
Members
Countdown to Brexit: Can your clinical supply chain pass the Brexit pressure test
Topics: Pharma Industry, Politics
White Paper
Members
EMA Guidance on Trial Mgmt during COVID-19
Topics: Health Care, Pharma Industry, Strategic Planning
Guidance Document
Free